1-3 of 3
John A McGrath, MD
Close
Sort by
Journal Articles

Reduced Intensity Conditioned Bone Marrow Transplant with Post-Transplant Cyclophosphamide and Donor-Derived Mesenchymal Stromal Cell Infusions for Recessive Dystrophic Epidermolysis Bullosa

Christen L. Ebens, MD MPH, John A McGrath, MD FRCP, FMedSci, Katsuto Tamai, MD PhD, Hovnanian Alain, MD PhD, John E. Wagner, MD, Megan Riddle, Douglas R Keene, BS, Todd E. DeFor, MS, Rebecca Tryon, MS, Mei Chen, PhD, David T Woodley, MD, Kristin Hook, MD, Jakub L Tolar, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2165.
https://doi.org/10.1182/blood-2018-99-113035
Published: 2018
Journal Articles

Mucocutaneous Engraftment and Type VII Collagen (C7) Replacement after Allogeneic Hematopoietic Cell Transplantation (HCT) in Patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Jakub Tolar, MD, PhD, John A McGrath, MD, Mark J. Osborn, PhD, Douglas R Keene, BS, Kristen Hook, MD, Maria Hordinsky, MD, David Woodley, MD, Mei Chen, PhD, Alain Hovnanian, MD PhD, Katsuto Tamai, MD PhD, Bruce R. Blazar, MD, John E Wagner, MD
Journal: Blood
Blood (2015) 126 (23): 402.
https://doi.org/10.1182/blood.V126.23.402.402
Published: 2015
Journal Articles

Allogeneic Hematopoietic Cell Transplantation for Severe Epidermolysis Bullosa: Impact of Conditioning Regimen and Stem Cell Source On Outcomes

Jakub Tolar, MD, PhD, John A. McGrath, MD, FRCP, Mark J. Osborn, PhD, Kristen P. Hook, MD, Douglas R. Keene, BS, Maria K. Hordinsky, MD, Bruce R. Blazar, MD, John E. Wagner, MD
Journal: Blood
Blood (2012) 120 (21): 965.
https://doi.org/10.1182/blood.V120.21.965.965
Published: 2012